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Abstract: This study assesses the impact of immigration in Friuli Venezia Giulia, a region of 
northeastern Italy, on the epidemiological features of hemoglobin patterns and on prothrombotic 
and trisomy risk in pregnancy for patients of non-Italian origin. This study follows a series of 
studies on the incidence of thalassemia and other hemoglobinopathies with reduced globin 
chain synthesis, that were performed during the postwar (1939–45) period in Friuli Venezia 
Giulia following immigration into the region from Istria and Sardinia (regions of northern and 
central Italy). Current data show that today’s constantly growing immigration into the region 
differs from previous decades, in terms of origin and quantity of migrants, who mainly come from 
third world countries. This has a significant impact on health care issues, and more specifically 
on prospective health screening for foreigners. The authors conclude that scholastic education 
and hospital services, either public or private, and voluntary associations, may contribute to 
solving the problem, but only in terms of training and organization, for non-European Union 
citizens arriving in northern Italy and neighboring areas, especially those from Africa, Asia, 
Latin America, and eastern Europe.
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Introduction
Immigration percentages in Friuli Venezia Giulia (FVG), a region with 1,200,000 
inhabitants and located in northeastern Italy, in the first decade of the   millennium were 
compared with data from other Italian regions over the same period, such as Latium, 
where immigrants accounted for 7.5% of total inhabitants, or Piedmont where 2.6% 
of university students were foreigners. The data were provided by the Italian Institute 
of Statistics. The comparison showed that FVG values were higher than the national 
average (1.6%). In particular, the main town of Trieste accounted for approximately 
4.5% of regional immigration. The current FVG data are even more marked, and 
indicate a constantly growing influx of immigrants who, to date, account for 7.7% of 
residents in the region.1 This immigration pattern has greater health care implications 
than in the past.
For instance, in the past, the provinces of Trieste and FVG were never typically 
affected by thalassemia. In the 1950s and 1960s, following immigration from areas 
with a high incidence of thalassemia and other hemoglobinopathies, such as Istria and 
Sardinia, the trait frequency first soared and later plummeted. Today,     immigration 
from African and Asian countries into Italy has contributed to the further diffusion of 
thalassemia and sickle cell disease, causing increased health care problems,   particularly Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
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with regard to blood transfusions in non-European Union 
patients affected by these diseases.2
Another example is the biochemical screening for 
Down syndrome, Edwards syndrome, fetal open neural tube 
defects, and spina bifida, a health care issue that requires 
renewed attention in light of the new immigration trends and 
the   frequent difficulties of communication and health care 
delivery. In Italy, an increased proportion of the population 
has been resorting to these screening tests because of the 
  availability of more accurate amniocentesis for detection of 
structural fetal anomalies. In Piedmont, for example, about 
197,000 pregnancies were evaluated by one laboratory between 
1990 and 2007, and the questionnaire provided to mothers by 
the Piedmont health care institutions required an indication 
of the patient’s country of origin. Knowledge of the native 
country is relevant because the median of the risk   calculation 
differs between African, Asian, and   Caucasian individuals. 
Consequently, and importantly, every   laboratory should cal-
culate the risk of malformations by using medians obtained 
from the local and the foreign population, because Asian and 
African women have higher levels of alpha   fetoprotein and the 
presence of a percentage of non-Caucasian women raises the 
median maternal serum alpha fetoprotein level.3
The aim of this work was to assess the impact of 
  immigration from third world countries on   epidemiological 
patterns in FVG, a region of northeastern Italy and an 
important gateway to Europe, and also to raise awareness 
and provide orientation for education on screening and 
identification of risk factors for transfusion problems in 
hemoglobinopathies (as alloimmunization of patients with 
sickle cell disease or thalassemia or thrombosis with abortion 
by antiphospholipid antibodies) and neonatal complications 
associated with abnormal maternal serum marker analysis 
(as free beta human chorionic gonadotropin hormone and 
protein A to diagnose Down and Edwards syndromes). 
Indeed, the genetic characteristics of Afro-Asians and 
eastern Europeans differ from locals for some pathologies, 
and it is difficult to study these problems in people with a 
limited grasp of the language and also because of economic 
  difficulties and sanitary problems. The screenings are less 
expensive when carried out during pregnancy. Hospitals, 
voluntary associations and public schools are greatly engaged 
to study hemoglobinopathies and risk factors for other fetal 
defects.
Materials and methods
Between January and December 2009 we reviewed diseases 
detected in subjects undergoing tests for medically assisted 
reproduction at the Children’s Hospital, Burlo Garofolo, 
  Trieste, where pregnant women from FVG are checked 
during pregnancy. The tests included hemoglobin patterns 
and the risk estimation for miscarriage, Down syndrome 
(T21), and Edwards syndrome (T18) in single and multiple 
pregnancies. We studied 774 pregnant women aged 37 years 
and older during gestational weeks 12 and 14 and undergoing 
prenatal ultrasonography at the prenatal diagnosis unit in our 
hospital, who consented to undergo combined biochemical 
screening because maternal age is an important risk factor 
for neonatal malformation.
All patients had to sign the informed consent form before 
entering the study, and enter the place of birth of the baby 
and its parent/s. According to the result section a patient 
questionnaire has been used.
Hemoglobin  was  analyzed  using  high-pressure 
  liquid   chromatography (with reference values for fetal 
hemoglobin $ 1.5% and hemoglobin A2 $ 3.2%). The blood 
count was performed using XE 2100 Dasit and ADVIA 120 
Siemens analyzers. These data were compared with those from 
  previous decades (1970–2000), during which hemoglobin 
patterns had been analyzed by electrophoresis (Helena Rep 
system with agarose gel), and using Hemalog 8/90, Technicon, 
and H1 Bayer analyzers for blood counts (reference values for 
mean corpuscular volume, M 80–94, F 81–99).
The so-called pregnancy-associated combined test 
  (bi-test) and prothrombotic risk factor test were performed 
Table 1 Phoresis of total hemoglobin: normal and pathological 
plots
Year 1975–76 1986–87 1995–96 2009
Normal Hb 302  
(59.92%)
439  
(78.96%)
382  
(76.40%)
516  
(66.93%)
Pathological Hb  202  
(40.08%)
117  
(21.04%)
118  
(23.60%)
258  
(33.07%)
Total 504 556 500 774
Abbreviation: Hb, hemoglobin.
Table  2  Total  figures  and  percentages  of  minor  and  major 
thalassemia
Year 1975–76 1986–87 1995–96 2009
Non-thalassemia  
phenotype 
302  
(59.92%)
440  
(79.13%)
385  
(77.00%)
518  
(66.93%)
HbF . 1.5% 55  
(10.91%)
34  
(6.12%)
9  
(1.80%) 
44  
(5.68%)
Hb A2 . 3.2% 126  
(25%)
64  
(11.51%)
101  
(20.20%)
160  
(20.67%)
Thalassemia major  
(HbF + A2)
21  
(4.17%)
18  
(3.24%)
5  
(1.00%)
52  
(6.72%)
Total 504 556 500 774
Abbreviation: Hb, hemoglobin.Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
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using plasma protein A (Perkin Elmer, Milan, Italy), 
the free beta subunit of human chorionic gonadotropin 
  hormone (Perkin Elmer), and antiphospholipid antibodies 
(Orgentec, Milan, Italy). Starting from the woman’s date of 
birth, the T21 and T18 risk was first calculated by   maternal 
age using an international software program, and then 
  determined after screening by estimating the risk according 
to the values of the three markers (fetal nuchal   translucency, 
plasma protein A, and the free beta subunit of human 
  chorionic gonadotropin hormone). The risk in dichorionic 
pregnancies was calculated separately for each fetus and 
a correction factor for twin pregnancies was applied to the 
values for biochemical markers expressed as the median of 
the risk calculation. However, in monochorionic   pregnancies, 
the same risk was attributed to both twins, assigning to both 
fetuses the highest of the two nuchal translucency values 
detected and the arithmetic average of the two crown rump 
length values observed. In this case too, a correction for 
twin pregnancies was applied to the biochemical markers 
expressed as the median of the risk calculation. No data were 
available from 1975 to 2009 for comparison.
Results
Hemoglobin tests were carried out on 774 patients from the 
Obstetrics and Gynecology Department at the Children’s 
Hospital in Burlo Garofolo and compared with the results 
from 1975–1976. Hemoglobin analysis detected the   presence 
of 258 abnormal hemoglobins, comprising 160 cases of minor 
thalassemia, 52 major thalassemias, and 44-S diseases, as well 
as different percentages of hemoglobin C and hemoglobin E. 
Membership of different ethnic groups, mainly Afro-Asian or 
eastern European, was confirmed using the patient question-
naire, and suggested the   percentage breakdown described 
in Table 1. Particularly significant was the predominance of 
subjects from Latin America (see Tables 1–5).
Of the pregnancies studied, all were singleton   pregnancies, 
but five were monochorionic twin pregnancies and 9 were 
dichorionic twin pregnancies. In 41 of the singleton 
  pregnancies, the combined test revealed a high risk only for 
trisomy 21. In one case, only an increased risk of trisomy 
18 was reported, and two pregnancies were at risk of both 
diseases. The remaining pregnancies were not at risk of 
either of these two aneuploids. The test was positive for 
Down syndrome in 5.3% of singleton pregnancies and for 
Edwards syndrome in 0.33%. However, in twin   pregnancies, 
the combined screening test revealed an increased risk of 
trisomy 21 in one monochorionic pregnancy and in three 
dichorionic pregnancies but, in all three cases, the   positive 
result concerned only one of the two fetuses. In single 
  pregnancies, the rate of false positives for trisomy 18 was 
0.27%, while for Down syndrome the rate would have been 
5.0% if all the fetuses that were at risk and whose karyotype 
is still unknown did not have T21. However, if some of these 
fetuses were affected by T21, the rate of false positives would 
be lower than 5.0%. With regard to Edwards syndrome, the 
rate of false positives was rather low, and the only fetus that 
was affected by the syndrome was detected through   maternal 
serum. The same alterations were found in fetuses with 
T18 where the presence of T21 can, in some cases, cause 
the test to indicate a higher risk of T18. Only two cases of 
  prothrombotic risk were detected (Table 6).
Discussion
Thalassemia includes a heterogeneous group of conditions 
sharing defective, reduced, or absent synthesis of one of the 
Table 3 Total figures and percentages of hemoglobin variants S, 
C, and e
Year 1975–76 1986–87 1995–96 2009
HbS 0 2 (0.36%) 4 (0.80%) 44 (5.68%)
HbC 0 0 2 (0.40%) 6 (0.78%)
Hbe 0 0 0 2 (0.26%)
Abbreviation: Hb, hemoglobin.
Table 4 Phoresis of total hemoglobin and hemoglobin fractions in the various periods. Presence of subjects with multiple pathological 
variants, both elevated, with alpha/beta chains (T)
Year Total Hb  HbF . 1.5% Hb A2 . 3.2% HbF + A2 HbS HbC HbS + T HbC + T HbS + C HbE
1975–76 504 76 
15.08%
147 
29.16%
21 
4.16%
0 0 0 0 0 0
1986–87 556 52 
9.35%
82 
14.75%
18 
3.24%
2 
0.36%
0 0 0 0 0
1995–96 500 14 
2.80%
106 
21.2%
5 
1.00%
4 
0.80%
2 
0.40%
2 
0.40%
0 0 0
2009 774 96 
12.4%
212 
27.4%
52 
6.72%
44 
5.68%
6 
0.78%
28 
3.61%
6 
0.78%
4 
0.52%
2 
0.26%
Abbreviation: Hb, hemoglobin.Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
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globin chains of hemoglobin. Although the   province of   Trieste 
has never been typically characterized by   thalassemia, the trait 
frequency has particularly increased following immigration 
from areas with a high incidence of   thalassemia, especially 
Istria and Sardinia during the 1950s and 1960s. The 9801 
cases examined by Molaro in FVG between 1978 and 1992 
(3212 in the province of Trieste, 3010 in the province of Udine, 
2990 in the province of Pordenone, and 589 in the province 
of Gorizia)   suggested a prevalence of the alpha   thalassemia 
trait (0.26%) and   individual   hemoglobin S and C diseases. The 
current data show a new rise of major   thalassemia (6.72%) 
and a   significant presence of   hemoglobin S (5.68%), in 
  addition to a more limited   percentage of   hemoglobin C and 
hemoglobin E. A   comparison with the recent past, despite the 
limited   percentage, showed no inconsistency with the current 
data, and no particular   prevalence or   incidence of hematologi-
cal diseases. Still pending are the questions related to medical 
and nursing training in   transfusion centers and   information 
given to foreigners (often requiring the   presence of a cultural 
mediator). The purpose of screening has changed, focusing 
not only on thalassemia but also on the prevention of other 
hereditary anemias, so there is a greater need for planning 
when it comes to blood donation schemes for non-European 
Union women.4,5 Study of the tests for the collection of cord 
blood is being enriched by data from legally compulsory tests 
as well as by essential elements for setting up a “universal 
data bank”.
Against such a background, the training of transfusion 
physicians in the field of diagnostic blood tests has to take 
into account and respect the cultural, social, and religious 
plurality of the different populations, in addition to having 
the necessary scientific knowledge and accuracy that comes 
from experience.
With regard to screening for fetal defects and   associated 
prothrombotic risk, on the basis of the data obtained in 
this study (rate of false positives, ability of detection, 
  appropriateness of reference medians), the so-called 
  combined test must be recommended for all pregnancies 
in mothers over 37 years of age, and it must be borne in 
mind that test performance is worse in twin pregnancies.6,7 
With regard to the associated prothrombotic risk, this study 
does not show any significant difference between European 
Union and   non-European Union women in the presence of 
  antiphospholipid antibodies.   However, in the group studied, 
considering the different antigens separately, all the tests were 
negative for IgG antibodies and the tests were positive for IgM 
in only two non-Caucasian women with medically treated 
dichorionic pregnancies, and in correlation with the risk.8,9
Conclusion
From the social point of view, the hemoglobin percentages 
found do not indicate a problem concerning blood           donation. 
However, due to the increased number of sickle cell disease 
cases (having a single mutation of the beta-globin gene), 
Table 5 Phoresis of total hemoglobin and hemoglobin fractions according to area of origin. Presence of subjects with multiple 
pathological variants (2009), with/without thalassemia fractions (T)
Origin Total Hb Pathological  
Hb
HbF .  
1.5%
Hb A2 . 
3.2%
HbF +  
A2
HbS HbC HbS +  
HbT
HbC +  
HbT
HbS +  
HbC 
HbE
Africa 28 12 
42.86%
10 
37.71%
8 
28.5%
6 
21.43%
12 
42.86%
6 
21.43%
0 0 0
Asia 74 32  
43.24%
24 
32.43%
24 
32.4%
16 + 21 
62%
10 
13.51%
2 
2.70%
8 
10.81%
2 
2.70%
0 2 
0.26%
Latin 
American
30 20 
66.66%
10 
33.33%
18 
60.0%
12 
40.00%
18 
60.00%
12 
40.00%
0 0 0
east  
Caucasian
64 18 
28.13%
4 
6.25%
16 
25.0%
2 
3.13%
0 0 0 0 0 0
West  
Caucasian
578 176 
30.45%
48 
8.30%
146 
25.2%
16 
2.77%
4 
0.70%
4 
0.70%
2 
0.35%
4 
0.70%
4 
0.70%
0
Abbreviation: Hb, hemoglobin
Table  6  Tests  with  high  risk  for  thrombosis.  The  analyzed 
samples were negative or uncertain for Ige and positive for IgM
Samples
1 2
IgG IgM IgG IgM
Antigens
β2GPI Neg Neg Neg Un
Cardiolipin + β2GPI  Un Un Neg Pos
Phosphatidyl serine + β2GPI  Neg Pos Neg Pos
Phosphatidyl inositol + β2GPI Neg Un Neg Pos
Phosphatidic acid + β2GPI Neg Un Neg Pos
Mix + β2GPI Un Pos Neg Pos
Mix without β2GPI Neg Pos Neg Pos
Abbreviations:  Neg,  negative;  Un,  uncertain;  Pos,  positive;  β2GPI,  beta2-
glycoprotein.Risk Management and Healthcare Policy
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particular attention should be paid to the transfusion of 
non-European Union patients with more severe conditions 
requiring regular transfusions for frequent hospitalization and 
surgery. In these cases, either molecular technology should 
be applied in order to best avoid alloimmunization or, in 
the light of the available resources and frequency, screening 
protocols should be set up for preventive purposes, as well 
as the identification of selected donors and prophylactic 
antigen matches.
This study has also shown that, in FVG, only 3% of 
  non-European Union women (versus 70% European Union 
citizens) are aware of and avail themselves of bitest   screening, 
This is of concern because the literature shows that Down 
and Edwards syndromes are more frequent in non-European 
than in European populations.10
Education, either public or private, through voluntary 
associations may contribute to solving the problem in terms of 
training and organization of blood donations and   biochemical 
screening in pregnancies for non-European Union women 
arriving in northern Italy and neighboring areas from Africa, 
Asia, Latin America, and eastern Europe.10–15
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